In contrast to CD8(+) T cell killing to cancer cells, T regulatory (Treg) cells exhibit immune tolerance and inhibit antitumor immunotherapy, and high levels of GPX4 in Treg cells prevent lipid peroxidation and ferroptosis. The gene discussed is CD8A; the disease is cancer.